Skip to main content
. 2021 Apr 18;210(2-3):133–147. doi: 10.1007/s00430-021-00707-4

Table 2.

Treatment of infected macrophages

Compound Concentration (µg/mL) Percentage of infected macrophages after treatment Infectiveness reduction (%) Number of amastigotes per macrophage
Acarbose 10.0 9.4 ± 0.7 87.4 0.1 ± 0
5.0 19.8 ± 2.6 73.4 0.5 ± 0.2
2.5 33.4 ± 5.4 55.1 1.4 ± 0.3
0 74.4 ± 5.5 (–) 3.3 ± 0.6
Amphotericin B 1.0 24.2 ± 3.0 67.5 1.1 ± 0.2
0.50 33.6 ± 4.0 54.8 1.8 ± 0.3
0.25 49.9 ± 3.5 32.9 2.6 ± 0.6
0 74.4 ± 5.5 (–) 3.3 ± 0.6

Murine macrophages (5 × 105 cells) were incubated in RPMI 1640 medium supplemented with 20% FBS and 20 mM l-glutamine at pH 7.4, for 24 h at 37 °C in 5% CO2. L. infantum stationary promastigotes were used to infect the macrophages (at a ratio of 10 parasites per one macrophage) for 48 h at 37 °C in 5% CO2. Free parasites were removed by extensive washing with medium and infected macrophages were treated with ACA (0, 2.5, 5.0 and 10.0 µg/mL) or AmpB (0, 0.25, 0.5 and 1.0 µg/mL) for 48 h at 24 °C in 5% CO2. Percentage of infected macrophages, infectiveness reduction and the number of recovered amastigotes per cell were determined by counting 200 macrophages, in triplicate. Results are expressed as mean ± standard deviation